Pfizer Inc. (FRA:PFE)

Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of EUR 120.04 billion. The enterprise value is 160.94 billion.

Market Cap	120.04B
Enterprise Value	160.94B

Important Dates

The last earnings date was Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	Nov 7, 2025

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.09%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 14.28 and the forward PE ratio is 7.88.

PE Ratio	14.28
Forward PE	7.88
PS Ratio	2.24
PB Ratio	1.51
P/TBV Ratio	n/a
P/FCF Ratio	13.53
P/OCF Ratio	10.73
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.25, with an EV/FCF ratio of 18.14.

EV / Earnings	19.15
EV / Sales	2.96
EV / EBITDA	7.25
EV / EBIT	10.46
EV / FCF	18.14

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.67.

Current Ratio	1.28
Quick Ratio	0.90
Debt / Equity	0.67
Debt / EBITDA	2.42
Debt / FCF	5.97
Interest Coverage	6.59

Financial Efficiency

Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 7.04%.

Return on Equity (ROE)	10.60%
Return on Assets (ROA)	5.19%
Return on Invested Capital (ROIC)	7.04%
Return on Capital Employed (ROCE)	10.33%
Revenue Per Employee	662,886
Profits Per Employee	103,775
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.36

Taxes

Income Tax	-585.81M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-15.47%
50-Day Moving Average	21.23
200-Day Moving Average	21.75
Relative Strength Index (RSI)	51.53
Average Volume (20 Days)	62,236

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.97

Income Statement

In the last 12 months, Pfizer had revenue of EUR 53.69 billion and earned 8.41 billion in profits. Earnings per share was 1.48.

Revenue	53.69B
Gross Profit	40.17B
Operating Income	15.20B
Pretax Income	7.83B
Net Income	8.41B
EBITDA	20.92B
EBIT	15.20B
Earnings Per Share (EPS)	1.48

Balance Sheet

The company has 12.81 billion in cash and 52.97 billion in debt, giving a net cash position of -40.16 billion.

Cash & Cash Equivalents	12.81B
Total Debt	52.97B
Net Cash	-40.16B
Net Cash Per Share	n/a
Equity (Book Value)	79.62B
Book Value Per Share	13.96
Working Capital	8.83B

Cash Flow

In the last 12 months, operating cash flow was 11.18 billion and capital expenditures -2.31 billion, giving a free cash flow of 8.87 billion.

Operating Cash Flow	11.18B
Capital Expenditures	-2.31B
Free Cash Flow	8.87B
FCF Per Share	n/a

Margins

Gross margin is 74.81%, with operating and profit margins of 28.31% and 15.66%.

Gross Margin	74.81%
Operating Margin	28.31%
Pretax Margin	14.58%
Profit Margin	15.66%
EBITDA Margin	38.96%
EBIT Margin	28.31%
FCF Margin	16.53%

Dividends & Yields

This stock pays an annual dividend of 1.53, which amounts to a dividend yield of 7.17%.

Dividend Per Share	1.53
Dividend Yield	7.17%
Dividend Growth (YoY)	-1.28%
Years of Dividend Growth	1
Payout Ratio	103.80%
Buyback Yield	-0.18%
Shareholder Yield	7.01%
Earnings Yield	7.00%
FCF Yield	7.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 1, 1999. It was a forward split with a ratio of 3.

Last Split Date	Jul 1, 1999
Split Type	Forward
Split Ratio	3

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7